 | • レポートコード：MRC2105A002 • 出版社/出版日：Persistence Market Research / 2020年12月 • レポート形態：英文、PDF、255ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Site Licence | ￥1,124,800 (USD7,600) | ▷ お問い合わせ |
| Enterprisewide | ￥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Persistence Market Research社の本調査レポートは、世界の生体適合性材料市場について調査し、エグゼクティブサマリー、市場概要、主要市場動向、主要成功要因、市場背景、新型コロナウイルス感染症の危機分析、市場分析/予測、材料別（ポリマー、金属、セラミック、複合材料）分析、用途別（手術・医療器具、インプラント、ドラックデリバリー、その他）分析、エンドユーザー別（医療機器メーカー、学術研究機関、バイオ医薬品・製薬企業）分析、地域別分析、市場構造分析、競争分析、仮定、調査手法などを掲載しています。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・主要成功要因 ・市場背景 ・新型コロナウイルス感染症の危機分析 ・市場分析/予測 ・世界の生体適合性材料市場規模：材料別（ポリマー、金属、セラミック、複合材料） ・世界の生体適合性材料市場規模：用途別（手術・医療器具、インプラント、ドラックデリバリー、その他） ・世界の生体適合性材料市場規模：エンドユーザー別（医療機器メーカー、学術研究機関、バイオ医薬品・製薬企業） ・世界の生体適合性材料市場規模：地域別 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Biocompatible Materials Market – Scope of Report
A latest publication by Persistence Market Research (PMR) on the global biocompatible materials market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the global biocompatible materials market. The study offers detailed insights on key market dynamics, which includes the drivers, restraints, trends, and opportunities in the biocompatible materials market. The principal aim of the market study is to present exclusive information about how the market will perform over the forecast period of 2020-2030.
Important indicators for the successful growth of the biocompatible materials market are presented in this comprehensive report, which include Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described in an exhaustive way in PMR’s research. This research study can support readers to know the demand for biocompatible materials and quantitative development opportunities during the study period.
The research is beneficial for shareholders in the biocompatible materials market, including market investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the biocompatible materials market. Insights and wisdom presented in this PMR study can be leveraged by shareholders in the biocompatible materials market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.
Market statistics as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the biocompatible materials market are also included in the current study. Depending on potential developments in the biocompatible materials market, substantive insights are also encountered in this report. Additionally, by virtue of the data submitted in this market report, minor companies and new entrants in the biocompatible materials industry can be aided in making suitable company choices to achieve traction in the biocompatible materials market.
Key Questions Answered in PMR’s Biocompatible Materials Market Report
Which regions will continue to remain the most profitable regional markets for biocompatible materials market players?
Which factors will induce a change in the demand for biocompatible materials during the assessment period?
How will changing trends impact the biocompatible materials market?
How can market players capture the low-hanging opportunities in the biocompatible materials market in developed regions?
What are the winning strategies of stakeholders in the biocompatible materials market to upscale their position in this landscape?
What are the restraints that investors need to be aware of and might tackle while investing in the biocompatible materials market?
What are the developmental trends in biocompatible material sectors that will impact the market?
How can businesses in the biocompatible materials market avail the growth opportunities in developed and emerging sectors?
Biocompatible Materials Market: Research Methodology
In PMR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the biocompatible materials market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the biocompatible materials market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the biocompatible materials market, and makes PMR’s projections on the growth prospects of the biocompatible materials market more accurate and reliable.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion and Exclusions
3. Key Market Trends
3.1. Key Manufacturing Trends
3.2. Manufacturing and Development Trends
3.3. Key Product features
4. Key Success Factors
4.1. Key Regulations
4.2. Product Adoption analysis
4.3. Medical Device Supply Chain Analysis
4.4. Material Type-Application matrix
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP outlook
5.1.2. Global Healthcare Outlook
5.1.3. Global Healthcare Expenditure Outlook
5.2. Forecast Factors – Relevance & Impact
5.2.1. Increasing number of surgeries
5.2.2. Increasing number of research activities
5.2.3. Cost of manufacturing Biocompatible materials
5.2.4. Adoption of biocompatible implants
5.2.5. Increasing Healthcare Expenditure & Disposable Income
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID19 Crisis Analysis
6.1. Current COVID19 Statistics and Probable Future Impact
6.2. Current GDP Projection and Probable Impact
6.3. Current Economic Projection as compared to 2008 Economic analysis
6.4. COVID19 and Impact Analysis, by Country
6.5. 2020 Market Scenario
6.6. Recovery Scenario – Short term, Midterm and Long Term Impact
7. Global Biocompatible Materials Market Demand Value (US$ Mn) Analysis 2015–2019 and Forecast, 2020–2030
7.1. Historical Market Value (US$ Mn) Analysis, 2015–2019
7.2. Current and Future Market Value (US$ Mn) Projections, 2020–2030
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Biocompatible Materials Market Analysis 2015–2019 and Forecast 2020–2030, by Material Type
8.1. Introduction / Key Findings
8.2. Historical Biocompatible Materials Market (US$ Mn) By Material Type, 2015–2019
8.3. Current and Future Biocompatible Materials Market (US$ Mn) Analysis and Forecast By Material Type, 2020–2030
8.3.1. Polymers
8.3.1.1.1. Natural
8.3.1.1.1.1. Hyaluronic Acid
8.3.1.1.1.2. Chitosan
8.3.1.1.1.3. Hydroxyapatite
8.3.1.1.1.4. Others
8.3.1.1.2. Synthetic
8.3.1.1.2.1. Polymethylmetacrylate (PMMA)
8.3.1.1.2.2. Polyurethane
8.3.1.1.2.3. Polyester
8.3.1.1.2.4. Polytetrafluoroethylene
8.3.1.1.2.5. Silicone
8.3.1.1.2.6. Polyethylenterephthalate
8.3.1.1.2.7. Others
8.3.2. Metal
8.3.3. Ceramic
8.3.4. Composites
8.4. Market Attractiveness Analysis By Material Type
9. Global Biocompatible Materials Market Analysis 2015–2019 and Forecast 2020–2030, by Application
9.1. Introduction / Key Findings
9.2. Historical Biocompatible Materials Market (US$ Mn) Analysis By Application, 2015–2019
9.3. Current and Future Biocompatible Materials Market (US$ Mn) Analysis and Forecast By Application, 2020–2030
9.3.1. Surgical & medical instruments
9.3.1.1.1. Brain surgery
9.3.1.1.2. Cosmetic and plastic surgery
9.3.1.1.3. Vascular surgery
9.3.1.1.4. Cardiovascular surgery
9.3.1.1.5. Others
9.3.2. Implants
9.3.2.1.1. Orthopedic
9.3.2.1.2. Cardiac
9.3.2.1.3. Dental
9.3.3. Drug delivery
9.3.4. Others
9.4. Market Attractiveness Analysis By Application
10. Global Biocompatible Materials Market Analysis 2015–2019 and Forecast 2020–2030, by End User
10.1. Introduction
10.2. Historical Biocompatible Materials Market (US$ Mn) Analysis By End User, 2015 – 2019
10.3. Current Biocompatible Materials Market (US$ Mn) Analysis and Forecast By End User, 2020 – 2030
10.3.1. Medical device manufacturers
10.3.2. Academic and research institutes
10.3.3. Biopharmaceutical & Pharmaceutical companies
10.4. Market Attractiveness Analysis By End User
11. Global Biocompatible Materials Market Analysis 2015–2019 and Forecast 2020–2030, by Region
11.1. Introduction
11.2. Historical Biocompatible Materials Market (US$ Mn) Analysis By Region, 2015 – 2019
11.3. Current Biocompatible Materials Market (US$ Mn) Analysis and Forecast By Region, 2020 – 2030
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Oceania
11.3.7. Middle East and Africa (MEA)
Market Attractiveness Analysis By Region
12. North America Biocompatible Materials Market Analysis 2015–2019 and Forecast 2020–2030
12.1. Introduction
12.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015–2019
12.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2020–2030
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Material Type
12.3.3. By Application
12.3.4. By End User
12.4. Market Attractiveness Analysis
12.5. Key Market Participants – Intensity Mapping
13. Latin America Biocompatible Materials Market Analysis 2015–2019 and Forecast 2020–2030
13.1. Introduction
13.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019
13.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2020–2030
13.3.1. By Country
13.3.1.1. Brazil
13.3.1.2. Mexico
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.2. By Material Type
13.3.3. By Application
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.5. Key Market Participants – Intensity Mapping
14. Europe Biocompatible Materials Market Analysis 2015–2019 and Forecast 2020–2030
14.1. Introduction
14.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015–2019
14.3. Market Value (US$ Mn) Forecast By Market Taxonomy2020–2030
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. U.K.
14.3.1.5. Spain
14.3.1.6. BENELUX
14.3.1.7. Russia
14.3.1.8. Rest of Europe
14.3.2. By Material Type
14.3.3. By Application
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.5. Key Market Participants – Intensity Mapping
15. South Asia Biocompatible Materials Market Analysis 2015–2019 and Forecast 2020–2030
15.1. Introduction
15.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015–2019
15.3. Market Value (US$ Mn) Forecast By Market Taxonomy2020–2030
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Thailand
15.3.1.3. Indonesia
15.3.1.4. Malaysia
15.3.1.5. Rest of South Asia
15.3.2. By Material Type
15.3.3. By Application
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.5. Key Market Participants – Intensity Mapping
16. East Asia Biocompatible Materials Market Analysis 2015–2019 and Forecast 2020–2030
16.1. Introduction
16.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015–2019
16.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2020–2030
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Material Type
16.3.3. By Application
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.5. Key Market Participants – Intensity Mapping
17. Oceania Biocompatible Materials Market Analysis 2015–2019 and Forecast 2020–2030
17.1. Introduction
17.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015–2019
17.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2020–2030
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Material Type
17.3.3. By Application
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.5. Key Market Participants – Intensity Mapping
18. Middle East and Africa Biocompatible Materials Market Analysis 2015–2019 and Forecast 2020–2030
18.1. Introduction
18.2. Historical Market Value (US$ Mn) Trend Analysis By Value Taxonomy, 2015–2019
18.3. Market Material (US$ Mn) Forecast By Market Taxonomy, 2020–2030
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Turkey
18.3.1.3. South Africa
18.3.1.4. Rest of Middle East and Africa
18.3.2. By Material Type
18.3.3. By Application
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.5. Key Market Participants – Intensity Mapping
19. Key & Emerging Countries Biocompatible Materials Market Analysis 2015–2019 and Forecast 2020–2030
19.1. U.S. Biocompatible Materials Market Analysis
19.1.1. By Material Type
19.1.2. By Application
19.1.3. By End User
19.2. Canada Biocompatible Materials Market Analysis
19.2.1. By Material Type
19.2.2. By Application
19.2.3. By End User
19.3. Brazil Biocompatible Materials Market Analysis
19.3.1. By Material Type
19.3.2. By Application
19.3.3. By End User
19.4. Argentina Biocompatible Materials Market Analysis
19.4.1. By Material Type
19.4.2. By Application
19.4.3. By End User
19.5. Mexico Biocompatible Materials Market Analysis
19.5.1. By Material Type
19.5.2. By Application
19.5.3. By End User
19.6. U.K. Biocompatible Materials Market Analysis
19.6.1. By Material Type
19.6.2. By Application
19.6.3. By End User
19.7. Germany Biocompatible Materials Market Analysis
19.7.1. By Material Type
19.7.2. By Application
19.7.3. By End User
19.8. France Biocompatible Materials Market Analysis
19.8.1. By Material Type
19.8.2. By Application
19.8.3. By End User
19.9. Italy Biocompatible Materials Market Analysis
19.9.1. By Material Type
19.9.2. By Application
19.9.3. By End User
19.10. Spain Biocompatible Materials Market Analysis
19.10.1. By Material Type
19.10.2. By Application
19.10.3. By End User
19.11. Russia Biocompatible Materials Market Analysis
19.11.1. By Material Type
19.11.2. By Application
19.11.3. By End User
19.12. India Biocompatible Materials Market Analysis
19.12.1. By Material Type
19.12.2. By Application
19.12.3. By End User
19.13. Malaysia Biocompatible Materials Market Analysis
19.13.1. By Material Type
19.13.2. By Application
19.13.3. By End User
19.14. Thailand Biocompatible Materials Market Analysis
19.14.1. By Material Type
19.14.2. By Application
19.14.3. By End User
19.15. Indonesia Biocompatible Materials Market Analysis
19.15.1. By Material Type
19.15.2. By Application
19.15.3. By End User
19.16. China Biocompatible Materials Market Analysis
19.16.1. By Material Type
19.16.2. By Application
19.16.3. By End User
19.17. Japan Biocompatible Materials Market Analysis
19.17.1. By Material Type
19.17.2. By Application
19.17.3. By End User
19.18. South Korea Biocompatible Materials Market Analysis
19.18.1. By Material Type
19.18.2. By Application
19.18.3. By End User
19.19. Australia Biocompatible Materials Market Analysis
19.19.1. By Material Type
19.19.2. By Application
19.19.3. By End User
19.20. New Zealand Biocompatible Materials Market Analysis
19.20.1. By Material Type
19.20.2. By Application
19.20.3. By End User
19.21. GCC Countries Biocompatible Materials Market Analysis
19.21.1. By Material Type
19.21.2. By Application
19.21.3. By End User
19.22. South Africa Biocompatible Materials Market Analysis
19.22.1. By Material Type
19.22.2. By Application
19.22.3. By End User
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Market Concentration
20.3. Market Share Analysis of Top Players
20.4. Market Presence Analysis
20.4.1. Regional footprint of Players
20.4.2. Channel Foot Print by Players
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep Dive
21.3.1. Dupont
21.3.1.1. Overview
21.3.1.2. Kit Portfolio
21.3.1.3. Profitability by Market Segments (Drug/Channel/Region)
21.3.1.4. Sales Footprint
21.3.1.5. Strategy Overview
21.3.1.5.1. Marketing Strategy
21.3.1.5.2. Drug Strategy
21.3.1.5.3. Channel Strategy
21.3.2. Ensinger
21.3.2.1. Overview
21.3.2.2. Kit Portfolio
21.3.2.3. Profitability by Market Segments (Drug/Channel/Region)
21.3.2.4. Sales Footprint
21.3.2.5. Strategy Overview
21.3.2.5.1. Marketing Strategy
21.3.2.5.2. Drug Strategy
21.3.2.5.3. Channel Strategy
21.3.3. Stratasys Ltd.
21.3.3.1. Overview
21.3.3.2. Kit Portfolio
21.3.3.3. Profitability by Market Segments (Drug/Channel/Region)
21.3.3.4. Sales Footprint
21.3.3.5. Strategy Overview
21.3.3.5.1. Marketing Strategy
21.3.3.5.2. Drug Strategy
21.3.3.5.3. Channel Strategy
21.3.4. Covestro AG
21.3.4.1. Overview
21.3.4.2. Kit Portfolio
21.3.4.3. Profitability by Market Segments (Drug/Channel/Region)
21.3.4.4. Sales Footprint
21.3.4.5. Strategy Overview
21.3.4.5.1. Marketing Strategy
21.3.4.5.2. Drug Strategy
21.3.4.5.3. Channel Strategy
21.3.5. Foster Corporation
21.3.5.1. Overview
21.3.5.2. Kit Portfolio
21.3.5.3. Profitability by Market Segments (Drug/Channel/Region)
21.3.5.4. Sales Footprint
21.3.5.5. Strategy Overview
21.3.5.5.1. Marketing Strategy
21.3.5.5.2. Drug Strategy
21.3.5.5.3. Channel Strategy
21.3.6. Merck KGaA
21.3.6.1. Overview
21.3.6.2. Kit Portfolio
21.3.6.3. Profitability by Market Segments (Drug/Channel/Region)
21.3.6.4. Sales Footprint
21.3.6.5. Strategy Overview
21.3.6.5.1. Marketing Strategy
21.3.6.5.2. Drug Strategy
21.3.6.5.3. Channel Strategy
21.3.7. BASF SE (Exxon Mobil Corporation)
21.3.7.1. Overview
21.3.7.2. Kit Portfolio
21.3.7.3. Profitability by Market Segments (Drug/Channel/Region)
21.3.7.4. Sales Footprint
21.3.7.5. Strategy Overview
21.3.7.5.1. Marketing Strategy
21.3.7.5.2. Drug Strategy
21.3.7.5.3. Channel Strategy
21.3.8. Wacker Chemie AG
21.3.8.1. Overview
21.3.8.2. Kit Portfolio
21.3.8.3. Profitability by Market Segments (Drug/Channel/Region)
21.3.8.4. Sales Footprint
21.3.8.5. Strategy Overview
21.3.8.5.1. Marketing Strategy
21.3.8.5.2. Drug Strategy
21.3.8.5.3. Channel Strategy
21.3.9. Celanese Corporation
21.3.9.1. Overview
21.3.9.2. Kit Portfolio
21.3.9.3. Profitability by Market Segments (Drug/Channel/Region)
21.3.9.4. Sales Footprint
21.3.9.5. Strategy Overview
21.3.9.5.1. Marketing Strategy
21.3.9.5.2. Drug Strategy
21.3.9.5.3. Channel Strategy
21.3.10. Royal DSM
21.3.10.1. Overview
21.3.10.2. Kit Portfolio
21.3.10.3. Profitability by Market Segments (Drug/Channel/Region)
21.3.10.4. Sales Footprint
21.3.10.5. Strategy Overview
21.3.10.5.1. Marketing Strategy
21.3.10.5.2. Drug Strategy
21.3.10.5.3. Channel Strategy
21.3.11. Evonik Industries AG
21.3.11.1. Overview
21.3.11.2. Kit Portfolio
21.3.11.3. Profitability by Market Segments (Drug/Channel/Region)
21.3.11.4. Sales Footprint
21.3.11.5. Strategy Overview
21.3.11.5.1. Marketing Strategy
21.3.11.5.2. Drug Strategy
21.3.11.5.3. Channel Strategy
21.3.12. Shin-Etsu Chemical Co. Ltd.
21.3.12.1. Overview
21.3.12.2. Kit Portfolio
21.3.12.3. Profitability by Market Segments (Drug/Channel/Region)
21.3.12.4. Sales Footprint
21.3.12.5. Strategy Overview
21.3.12.5.1. Marketing Strategy
21.3.12.5.2. Drug Strategy
21.3.12.5.3. Channel Strategy
21.3.13. Henkel AG & Co.
21.3.13.1. Overview
21.3.13.2. Kit Portfolio
21.3.13.3. Profitability by Market Segments (Drug/Channel/Region)
21.3.13.4. Sales Footprint
21.3.13.5. Strategy Overview
21.3.13.5.1. Marketing Strategy
21.3.13.5.2. Drug Strategy
21.3.13.5.3. Channel Strategy
22. Assumptions and Acronyms Used
23. Research Methodology
Table 01: Global Biocompatible Materials Market Size (US$ Bn) Analysis 2015–2019 and Forecast 2020–2030, By Material TypeTable 02: Global Biocompatible Materials Market Size (US$ Bn) Analysis 2015–2019 and Forecast 2020–2030, By Application
Table 03: Global Biocompatible Materials Market Size (US$ Bn) Analysis 2015–2019 and Forecast 2020–2030, By End User
Table 04: Global Biocompatible Materials Market Size (US$ Bn) Analysis 2015–2019 and Forecast 2020–2030, By Region
Table 05: North America Biocompatible Materials Market Size (US$ Bn) Analysis 2015–2019 and Forecast 2020–2030, By Country
Table 06: North America Biocompatible Materials Market Size (US$ Bn) Analysis 2015–2019 and Forecast 2020–2030, By Material Type
Table 07: North America Biocompatible Materials Market Size (US$ Bn) Analysis 2015–2019 and Forecast 2020–2030, By Application
Table 08: North America Biocompatible Materials Market Size (US$ Bn) Analysis 2015–2019 and Forecast 2020–2030, By End User
Table 09: Latin America Biocompatible Materials Market Size (US$ Bn) Analysis 2015–2019 and Forecast 2020–2030, By Country
Table 10: Latin America Biocompatible Materials Market Size (US$ Bn) Analysis 2015–2019 and Forecast 2020–2030, By Material Type
Table 11: Latin America Biocompatible Materials Market Size (US$ Bn) Analysis 2015–2019 and Forecast 2020–2030, By Application
Table 12: Latin America Biocompatible Materials Market Size (US$ Bn) Analysis 2015–2019 and Forecast 2020–2030, By End User
Table 13: Europe Biocompatible Materials Market Size (US$ Bn) Analysis 2015–2019 and Forecast 2020–2030, By Country
Table 14: Europe Biocompatible Materials Market Size (US$ Bn) Analysis 2015–2019 and Forecast 2020–2030, By Material Type
Table 15: Europe Biocompatible Materials Market Size (US$ Bn) Analysis 2015–2019 and Forecast 2020–2030, By Application
Table 16: Europe Biocompatible Materials Market Size (US$ Bn) Analysis 2015–2019 and Forecast 2020–2030, By End User
Table 17: South Asia Biocompatible Materials Market Size (US$ Bn) Analysis 2015–2019 and Forecast 2020–2030, By Country
Table 18: South Asia Biocompatible Materials Market Size (US$ Bn) Analysis 2015–2019 and Forecast 2020–2030, By Material Type
Table 19: South Asia Biocompatible Materials Market Size (US$ Bn) Analysis 2015–2019 and Forecast 2020–2030, By Application
Table 20: South Asia Biocompatible Materials Market Size (US$ Bn) Analysis 2015–2019 and Forecast 2020–2030, By End User
Table 21: East Asia Biocompatible Materials Market Size (US$ Bn) Analysis 2015–2019 and Forecast 2020–2030, By Country
Table 22: East Asia Biocompatible Materials Market Size (US$ Bn) Analysis 2015–2019 and Forecast 2020–2030, By Material Type
Table 23: East Asia Biocompatible Materials Market Size (US$ Bn) Analysis 2015–2019 and Forecast 2020–2030, By Application
Table 24: East Asia Biocompatible Materials Market Size (US$ Bn) Analysis 2015–2019 and Forecast 2020–2030, By End User
Table 25: Oceania Biocompatible Materials Market Size (US$ Bn) Analysis 2015–2019 and Forecast 2020–2030, By Country
Table 26: Oceania Biocompatible Materials Market Size (US$ Bn) Analysis 2015–2019 and Forecast 2020–2030, By Material Type
Table 27: Oceania Biocompatible Materials Market Size (US$ Bn) Analysis 2015–2019 and Forecast 2020–2030, By Application
Table 28: Oceania Biocompatible Materials Market Size (US$ Bn) Analysis 2015–2019 and Forecast 2020–2030, By End User
Table 29: Middle East & Africa Biocompatible Materials Market Size (US$ Bn) Analysis 2015–2019 and Forecast 2020–2030, By Country
Table 30: Middle East & Africa Biocompatible Materials Market Size (US$ Bn) Analysis 2015–2019 and Forecast 2020–2030, By Material Type
Table 31: Middle East & Africa Biocompatible Materials Market Size (US$ Bn) Analysis 2015–2019 and Forecast 2020–2030, By Application
Table 32: Middle East & Africa Biocompatible Materials Market Size (US$ Bn) Analysis 2015–2019 and Forecast 2020–2030, By End User